RNAi Therapeutics

Pages

▼
Showing posts with label EP1309726. Show all posts
Showing posts with label EP1309726. Show all posts
Friday, March 9, 2012

Silence Strongly Disagrees with Alnylam’s Version of Tuschl I Hearing

›
On February 29, there was a hearing on the Tuschl I patent in Europe (EP 1309726; co-owners: UMass, MIT, Max-Planck, the Whitehead; license...
3 comments:
›
Home
View web version
Powered by Blogger.